26 Mar 2021
Medika Natura CEO, Abdul Razak Mohd Isa, has been appointed as subject matter expert in research and development (R&D) with the Malaysian Ministry of Science, Technology and Innovation (MOSTI) Part of the job scope of the three-year appointment involves providing... 
25 Mar 2021
Medika Natura CEO, Abdul Razak Mohd Isa, has been appointed as an Adjunct Professor at the Institute of Systems Biology (INBIOSIS) at the National University of Malaysia (UKM) Razak’s two-year appointment will involve connecting INBIOSIS with research and industry... 
22 Mar 2021
Phase 2 clinical studies of SKF7™ conducted in Indonesia is the first Malaysian-led anti-obesity study to be registered on ClinicalTrials.gov, the world’s largest clinical trial database. Medika Natura has initiated Phase 2 in-human clinical trials on its proprietary... 
1 Mar 2021
Medika Natura’s proprietary product SKF7™ is the first native Malaysian ingredient to be officially listed on Regulations.gov Medika Natura’s proprietary product SKF7™ is the first native Malaysian ingredient to be listed on the Regulations.gov website and the first... 
23 Feb 2021
Medika Natura CEO and COO Abdul Razak Mohd Isa and Mustadza Muhamad presented to international investors and distributors at The Nutritional Capital Network Investor Meeting (NCNIM) 2020. The objective of the presentation which took place last October, was to attract... 
13 Feb 2021
Medika Natura CEO, Abdul Razak Mohd Isa, drew a record number of 140 attendees to his talk, which was part of the University Technology Malaysia (UTM) MTDC CEO lecture series. Held over Zoom last November, the digital lecture entitled “Membangun Perniagaan yang Mampan... 